CD4 and neoplasm: Moreover, treatment with CDK4/6is also resulted in a reduction in the circulating myeloid-derived suppressor cell (MDSC) population (known as the queen bee of the tumor microenvironment) while preserving other T-cell subsets such as CD8+ and CD4+ T cells [135].